|
|
|
|
LEADER |
01795nam a2200361 i 4500 |
001 |
659feda8-6412-4810-976f-bec00d07ab9b |
005 |
20230616000000.0 |
008 |
760830s1976 mdua b f000 0 eng d |
010 |
|
|
|a 76015843
|
020 |
|
|
|b pbk. :
|c $6.00 ;
|b mf :
|c $2.25
|
035 |
|
|
|a (DGPO)76006774
|
035 |
|
|
|a (OCoLC-M)2404922
|
040 |
|
|
|a GPO
|c GPO
|d MvI
|d OrLoB
|
049 |
|
|
|a STFD
|c c1
|
074 |
|
|
|a 831-C-8
|
086 |
|
|
|a HE 20.8216:7
|
100 |
1 |
|
|a Willette, Robert E
|
245 |
1 |
0 |
|a Cannabinoid assays in humans /
|c editor, Robert E. Willette
|
260 |
|
|
|a Rockville, Md. :
|b U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse ;
|a Springfield, Va. :
|b for sale by the National Technical Information Service,
|c 1976
|
300 |
|
|
|a xi, 120 p. :
|b ill. ;
|c 27 cm
|
490 |
1 |
|
|a DHEW publication ; no. (ADM) 76-339
|
490 |
1 |
|
|a National Institute on Drug Abuse research monograph series ;
|v no. 7
|
504 |
|
|
|a Includes bibliographical references
|
596 |
|
|
|a 1
|
650 |
|
0 |
|a Biological assay
|
650 |
|
0 |
|a Cannabis
|x Physiological effect
|
650 |
|
0 |
|a Marijuana
|x Physiological effect
|
650 |
|
2 |
|a Narcotic Antagonists
|
710 |
2 |
|
|a National Institute on Drug Abuse
|b Division of Research.
|
830 |
|
0 |
|a DHEW publication
|v no. (ADM) 76-339
|
830 |
|
0 |
|a National Institute on Drug Abuse research monograph series
|v 7
|
999 |
1 |
0 |
|i 659feda8-6412-4810-976f-bec00d07ab9b
|l a2521976
|s US-CST
|m cannabinoid_assays_in_humans_______________________________________________1976_______usdepa________________________________________willette__robert_e_________________he_20_8216_7e
|
999 |
1 |
1 |
|l a2521976
|s ISIL:US-CST
|t BKS
|a GREEN FED-DOCS
|b 36105223125662
|c HE 20.8216:7
|d SUDOC
|x GOVSTKS
|y 36105223125662
|p LOANABLE
|